Decreased IL-2 responses in ICL. by Florence Bugault (278171)

Decreased IL-7 responses in ICL. by Florence Bugault (278171)

“…<p>(A) Example of pSTAT5 response to IL-7 stimulation measured in whole blood from a healthy donor. …”

Sphingomyelinase activity decreases in Alzheimer’s disease. by Alfred N. Fonteh (486638)

CDA-2 decreases pulmonary inflammation. by Xuan Wang (55634)

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

Bioluminescence decreases with aging in transgenic mice. by Sarah E. Mailhiot (766685)

Serum estradiol concentrations in study (n = 9) and control (n = 5) bitches during the luteal phase, from days 8 to 27 after the estimated LH peak. by Kamil Kacprzak (713647)

Serum progesterone concentrations in study (n = 9) and control (n = 5) bitches during the luteal phase, from days 8 to 27 after the estimated LH peak. by Kamil Kacprzak (713647)

TIG3 decreases cell survival. by Tiffany M. Scharadin (345930)

“…<b>A</b> TIG3 expression decreases cell number. Values are mean ± SEM, n = 3. …”

The OKR of AhR−/− mice is decreased. by Aline Chevallier (105605)

“…<p>(A) Example of eye movements evoked in both AhR+/+ and AhR−/− mice in horizontal position (EHp) during a rotation at 5°/sec in light in counter-clockwise. …”

A flow diagram of the study entry. by Sakiko Fukui (387048)

“…</p><p>Methods</p><p>Sixty-nine deceased older adults from five special nursing homes were studied over 3.5 years (January 2016 to June 2020). …”

Cholesterol oxidation decreases membrane order. by Maarit Neuvonen (195662)

Decrease of bnAb activity during cell-cell transmission is variable and strain-dependent. by Lucia Reh (546554)

Decreased mutagen susceptibility of WNV replication complex mutants. by Greta A. Van Slyke (761322)

Pharmacological inhibition of EGFR decreases reduces a subset of the inflammatory response at day 2 post-infection. by Marc Swidergall (185453)

Decreased immunofluorescence during multiplex staining. by Sandrine Prost (38667)

“…<p>Serial sections were stained with 1 to 5 different markers (Marker 1, MHCII Qdot 705Vivid; Marker 2, HO1 Qdot 605Vivid; Marker 3, CD163 Qdot 565; Marker 4, CD206 Qdot 655Vivid; Marker 5, CD68 streptavidin Qdot 525). …”

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…<p>At higher concentrations, METH increases baseline synaptic transmission and decreases LTP. (<b>A</b>) Summary plot of normalized fEPSP slope measurements recorded in the CA1 region of the hippocampus. …”

βL decreases body mass. by Jeong-sook Lee (127654)

Trial profile. by Chanel Avenant (409756)

“…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”

Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)